Ledger.Open graph →

SEC Form D · filed August 9, 2018

Beam Therapeutics Inc

Offering

—

Sold

$45.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

John Evans · Grand Rapids, MIExec · Director Feng Zhang · Ann Arbor, MIDirector Kristina Burow · Chicago, ILDirector Robert Nelson · San Diego, CADirector John Evans · Charlotte, VTExec · Director Stephen Knight · WOBURN, MADirector Feng Zhang · Shanghai, IsraelDirector Mark Fishman · Chicago, ILDirector Kristina Burow · Ann Arbor, MIDirector Robert Nelson · Carlsbad, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗